News

Phase Forward has launched Empirica Study, formerly the Clinical Trials Signal Detection product (CTSD). The product helps clinical and safety teams to improve their understanding of a product’s

Inaccurate test results may fail to indicate HIV in an infected individual, or indicate HIV when none is present. Under the Medical Devices Regulations, home HIV test kits

Eurand has reported that FDA has extended the June 2009 user fee goal date for the New Drug Application for Zenpep, by three months. Zenpep is a proprietary

BRAHMS, Cezanne, and Lumiphore have signed an agreement to incorporate Lumiphore’s Lumi4 -Tb complexes in BRAHMS diagnostic tests. Lumi4-Tb would increase sensitivity of BRAHMS diagnostic tests and allow

In February 2008, the US District Court for the Central District of California awarded CombiMatrix $31.2 Million in its lawsuit against National Union Fire Insurance Company of Pittsburg,

Biomodels has announced that its customized research program allowed ActoGeniX to get FDA approval for phase 1b clinical trials of AGO13, in cancer patients with oral mucositis. The

China Sky One Medical (CSOM) has received approvals from the State Food and Drug Administration (SFDA) in China, for the production of Geranium ointment and Musk liniment for

Emisphere and Syracuse University have entered into a research agreement to combine Emisphere’s Eligen oral drug delivery technology with a new oral drug delivery system developed in the

Amicus has initiated phase-III trial with its investigational drug, Amigal (migalastat hydrochloride), for the treatment of Fabry disease. The company has reached an agreement with FDA on the